Val-ILs-?CD19 efficiently induces the death of human CD19+ cells. Credit: Cell Death & Disease (2024). DOI: 10.1038/s41419-024-06715-5 Valrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death & Disease describes the repurposing of this molecule for the creation of valrubicin-loaded immunoliposomes (Val-ILs). Due to its lipophilic nature, valrubicin easily integrates into the lipid composition of the nanoparticles, allowing it to target immunosuppressive cells effectively once injected into the body, thus treating cancers efficiently. When injected Read More